scholarly article | Q13442814 |
P50 | author | Dennis W. Dickson | Q30504740 |
Ronald C. Petersen | Q56839853 | ||
David S Knopman | Q63967707 | ||
Joseph E Parisi | Q67209577 | ||
Bradley F Boeve | Q67501037 | ||
Gregory A Jicha | Q92594727 | ||
Ruth H Cha | Q114336674 | ||
Glenn E. Smith | Q46205917 | ||
P2093 | author name string | Kris A Johnson | |
P2860 | cites work | “Mini-mental state” | Q25938989 |
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 | ||
Neuropathological stageing of Alzheimer-related changes | Q27860862 | ||
Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins | Q28168105 | ||
APOE genotype effects on Alzheimer's disease onset and epidemiology | Q28265282 | ||
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease | Q29614948 | ||
The Clinical Dementia Rating (CDR): current version and scoring rules | Q29616280 | ||
Vascular pathologies and cognition in a population-based cohort of elderly people | Q30975914 | ||
Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia | Q33340612 | ||
Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). | Q33935314 | ||
Age-associated prevalence and risk factors of Lewy body pathology in a general population: the Hisayama study | Q34220529 | ||
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease | Q34321510 | ||
Mayo Clinic Alzheimer's Disease Patient Registry. | Q52054751 | ||
Alzheimer's disease with and without coexisting Parkinson's disease changes: apolipoprotein E genotype and neuropathologic correlates. | Q53199687 | ||
The apolipoprotein E allele epsilon 4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease. | Q53204624 | ||
Neuropathology in controls and demented subjects from the Baltimore Longitudinal Study of Aging. | Q53212473 | ||
Vascular risks and incident dementia: results from a cohort study of the very old. | Q53223154 | ||
Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study. | Q53243175 | ||
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. | Q55042329 | ||
Cortical and subcortical argyrophilic grains characterize a disease associated with adult onset dementia | Q69072601 | ||
The importance of cerebral lesions of vascular origin in the morphopathologic picture of old age dementia | Q69731229 | ||
Diagnosis of Alzheimer's disease | Q69871134 | ||
Prevalence of cerebral vascular amyloid-beta deposition and stroke in an aging Australian population: a postmortem study | Q73127224 | ||
Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease | Q73789480 | ||
Lewy body-related alpha-synucleinopathy in aging | Q80410949 | ||
Statins, incident Alzheimer disease, change in cognitive function, and neuropathology | Q80503048 | ||
Staging of argyrophilic grains: an age-associated tauopathy | Q80797442 | ||
Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease | Q34509732 | ||
Genetic association between the APOE*4 allele and Lewy bodies in Alzheimer disease. | Q34709035 | ||
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop | Q34736093 | ||
Mixed dementia: epidemiology, diagnosis, and treatment | Q34775417 | ||
Dementia epidemiology | Q34777681 | ||
Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century | Q35172345 | ||
Dementia with Lewy bodies according to the consensus criteria in a general population aged 75 years or older | Q35474145 | ||
Genetic risk factors for stroke and carotid atherosclerosis: insights into pathophysiology from candidate gene approaches | Q35708128 | ||
Atherosclerotic Vascular Disease Conference: Writing Group I: epidemiology | Q35789818 | ||
Alzheimer's disease is a vasocognopathy: a new term to describe its nature | Q35841706 | ||
Pathogenic factors in vascular dementia and Alzheimer's disease. Multiple actions of heparin that probably are beneficial | Q35852208 | ||
Neurodegenerative diseases: insights into pathogenic mechanisms from atherosclerosis | Q36003471 | ||
Argyrophilic grain disease: a late-onset dementia with distinctive features among tauopathies | Q36004991 | ||
Cerebrovascular disease and the pathophysiology of Alzheimer's disease. Implications for therapy. | Q36118169 | ||
Applicability of current staging/categorization of alpha-synuclein pathology and their clinical relevance | Q36501660 | ||
Assessing the cognitive impact of Alzheimer disease pathology and vascular burden in the aging brain: the Geneva experience | Q36621520 | ||
Neuropathological aspects of Alzheimer disease, Parkinson disease and frontotemporal dementia | Q37102977 | ||
Neuropathology of older persons without cognitive impairment from two community-based studies | Q38405842 | ||
Argyrophilic grain disease is a sporadic 4-repeat tauopathy | Q39527344 | ||
Brain infarction and the clinical expression of Alzheimer disease. The Nun Study | Q42435324 | ||
The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity | Q42479244 | ||
Risk factors for cerebral amyloid angiopathy in the elderly | Q43519767 | ||
Incidence of stroke in relation to cognitive function and dementia in the Kungsholmen Project | Q44705300 | ||
The incidence of dementia: a meta-analysis | Q45174488 | ||
The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant | Q46323718 | ||
Mixed brain pathologies account for most dementia cases in community-dwelling older persons | Q48136681 | ||
Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series | Q48212849 | ||
Accumulation of phosphorylated alpha-synuclein in aging human brain | Q48266774 | ||
Neuropathology of white matter changes in Alzheimer's disease and vascular dementia. | Q48406159 | ||
Alzheimer's disease and brain infarcts in the elderly. Agreement with neuropathology | Q48452142 | ||
Neuropathologic evidence that the Lewy body variant of Alzheimer disease represents coexistence of Alzheimer disease and idiopathic Parkinson disease | Q48463134 | ||
Postmortem MRI and histopathology of white matter changes in Alzheimer brains. A quantitative, comparative study | Q48608182 | ||
Increased frequency of argyrophilic grain disease in Alzheimer disease with 4R tau-specific immunohistochemistry | Q48946568 | ||
Lewy body-related alpha-synucleinopathy in the aged human brain. | Q50282783 | ||
Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. | Q51125007 | ||
Vascular Dementia in a Population-Based Autopsy Study | Q51949169 | ||
Mild cognitive impairment in the oldest old. | Q51950636 | ||
P433 | issue | 1-2 | |
P921 | main subject | Alzheimer's disease | Q11081 |
P304 | page(s) | 34-39 | |
P577 | publication date | 2008-07-23 | |
P1433 | published in | Journal of the Neurological Sciences | Q6296168 |
P1476 | title | Age and apoE associations with complex pathologic features in Alzheimer's disease | |
P478 | volume | 273 |
Q35231770 | Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies |
Q36175429 | Antemortem Prediction of Braak Stage |
Q36395714 | Brain pathologies in extreme old age. |
Q24599735 | Conceptual evolution in Alzheimer's disease: implications for understanding the clinical phenotype of progressive neurodegenerative disease |
Q35529951 | Neuropathologic features associated with Alzheimer disease diagnosis: age matters |
Q35633470 | Preclinical AD Workgroup staging: pathological correlates and potential challenges. |
Q64269936 | Primary Age-Related Tauopathy: An Elderly Brain Pathology Frequently Encountered during Autopsy |
Q36862597 | Substantia nigra depigmentation and exposure to encephalitis lethargica. |
Q34550595 | Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART). |
Q91451096 | Tau and TDP-43 proteinopathies: kindred pathologic cascades and genetic pleiotropy |
Q36957279 | The occurrence of cerebrovascular atherosclerosis in Alzheimer's disease patients |
Q47907796 | Vascular Contributions in Alzheimer's Disease-Related Neuropathological Changes: First Autopsy Evidence from a South Asian Aging Population |
Search more.